<unk> , sold under the trade name Ingrezza, is a medication used to treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor.
Valbenazine
Brinzolamide
Nitroxazepine
Ranolazine
Brotizolam
Benazepril
Methyldopa
Propranolol